Live Breaking News & Updates on Kalvista Pharmaceuticals Daily

Stay updated with breaking news from Kalvista pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Insider Edward P. Feener Sells 8,088 Shares

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) insider Edward P. Feener sold 8,088 shares of the company’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $11.76, for a total value of $95,114.88. Following the sale, the insider now directly owns 72,858 shares in […] ....

United States , Edwardp Feener , Kalvista Pharmaceuticals , Entrypoint Capital , Institutional Trading Of Kalvista Pharmaceuticals , China Universal Asset Management Co , Tower Research Capital , Needham Company , Quarter For Kalvista Pharmaceuticals , Kalvista Pharmaceuticals Inc , Kalvista Pharmaceuticals Stock Performance , News Ratings For Kalvista Pharmaceuticals Daily , Get Free Report , Vista Pharmaceuticals , Research Capital , Universal Asset Management , Kalvista Pharmaceuticals Daily ,

AJOVista LLC Acquires Shares of 4,920 KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)

AJOVista LLC Acquires Shares of 4,920 KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Benjaminl Palleiko , Kalvista Pharmaceuticals Inc , Needham Company , Kalvista Pharmaceuticals Company Profile , Quarter For Kalvista Pharmaceuticals , China Universal Asset Management Co , Securities Exchange Commission , Kalvista Pharmaceuticals Stock Down , Insider Transactions At Kalvista Pharmaceuticals , Kalvista Pharmaceuticals , Principal Financial Group Inc , York State Common Retirement Fund , Exchange Commission , News Ratings For Kalvista Pharmaceuticals Daily , Free Report , Universal Asset Management , Principal Financial Group , Vista Pharmaceuticals Stock Down , Vista Pharmaceuticals , Get Free Report , Venrock Healthcare Capital Par , Visit Holdingschannel , Kalvista Pharmaceuticals Daily ,

HC Wainwright Trims KalVista Pharmaceuticals (NASDAQ:KALV) Target Price to $20.00

KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) had its price objective reduced by HC Wainwright from $24.00 to $20.00 in a research report report published on Friday morning, Benzinga reports. They currently have a buy rating on the specialty pharmaceutical company’s stock. Separately, Needham & Company LLC reiterated a buy rating and set a $35.00 price […] ....

United States , New York , Benjaminl Palleiko , Kalvista Pharmaceuticals Company Profile , Kalvista Pharmaceuticals Price Performance , China Universal Asset Management Co , Tower Research Capital , Kalvista Pharmaceuticals , York State Common Retirement Fund , News Ratings For Kalvista Pharmaceuticals Daily , Hedge Funds Weigh In On Kalvista Pharmaceuticals , Needham Company , Securities Exchange Commission , Kalvista Pharmaceuticals Inc , Free Report , Vista Pharmaceuticals , Get Free Report , Venrock Healthcare Capital Par , Exchange Commission , Research Capital , Universal Asset Management , New York State Common Retirement Fund , Kalvista Pharmaceuticals Daily , Nasdaq Kalv , Lower Price Target , Hc Wainwright ,

KalVista Pharmaceuticals (NASDAQ:KALV) Price Target Cut to $20.00

KalVista Pharmaceuticals (NASDAQ:KALV) Price Target Cut to $20.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Benjaminl Palleiko , Kalvista Pharmaceuticals , News Ratings For Kalvista Pharmaceuticals Daily , Nan Fung Group Holdings Ltd , Frazier Life Sciences Management , Kalvista Pharmaceuticals Company Profile , Needham Company , Sg Americas Securities , Affinity Asset Advisors , Kalvista Pharmaceuticals Stock Down , Kalvista Pharmaceuticals Inc , Insider Transactions At Kalvista Pharmaceuticals , Securities Exchange Commission , Vanguard Group Inc , Get Free Report , Vista Pharmaceuticals Stock Down , Vista Pharmaceuticals , Exchange Commission , Venrock Healthcare Capital Par , Asset Advisors , Fung Group Holdings Ltd , Kalvista Pharmaceuticals Daily ,

KalVista Pharmaceuticals (NASDAQ:KALV) Receives "Buy" Rating from Needham & Company LLC

KalVista Pharmaceuticals (NASDAQ:KALV) Receives "Buy" Rating from Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Benjaminl Palleiko , Edwardp Feener , Institutional Investors Weigh In On Kalvista Pharmaceuticals , Needham Company , Kalvista Pharmaceuticals Inc , Frazier Life Sciences Management , Vanguard Group Inc , Kalvista Pharmaceuticals Trading , Affinity Asset Advisors , Securities Exchange Commission , News Ratings For Kalvista Pharmaceuticals Daily , Nan Fung Group Holdings Ltd , Kalvista Pharmaceuticals , Sg Americas Securities , Free Report , Vista Pharmaceuticals , Get Free Report , Exchange Commission , Asset Advisors , Fung Group Holdings Ltd , Kalvista Pharmaceuticals Daily ,